Fair 73°
Tag:

SARS-CoV-2

Business
COVID-19: Recall Issued For Brand Of Over-Counter Tests That Could Give False Negative Results COVID-19: Recall Issued For Brand Of Over-Counter Tests That Could Give False Negative Results
Covid-19: Recall Issued For Brand Of Over-Counter Tests That Could Give False Negative Results A new recall has been issued for a brand of COVID-19 tests due to an increased chance that the tests may give false negative results Detect, Inc. is voluntarily recalling specific lots of the Detect COVID-19 Test, an over-the-counter test used to identify SARS-CoV-2 (the virus that causes COVID-19) in self-collected nasal swabs. The recall affects 11,102 tests shipped to customers from July 26, 2022, through Aug. 26, 2022, the company said. The test was granted Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) in October, 2021. There is an increased chance t…

SHARE

by Joe Lombardi
Lifestyle
COVID-19: CT Cancer Patient Has Been Infected With Virus At Least 471 Days, Case Study Says COVID-19: CT Cancer Patient Has Been Infected With Virus At Least 471 Days, Case Study Says
Covid-19: CT Cancer Patient Has Been Infected With Virus At Least 471 Days, Case Study Says A Connecticut resident experienced a chronic COVID-19 infection for at least 471 days, researchers reported. Researchers from Yale University found that a patient, who is diagnosed with lymphoma, has been testing positive for the virus for at least 471 days and that the virus rapidly mutated during their infection, according to the Daily Mail. The study, which has not yet been peer-reviewed, can be found here. Researchers reported that their surveillance system captured 30 nasal swabs from the unnamed individual, and sequenced COVID-19 genomes from day 79 through 471, which was between Feb…

SHARE

by Nicole Valinote
News
COVID-19: Moderna Seeks Vaccine Authorization For Kids Under Age 6 COVID-19: Moderna Seeks Vaccine Authorization For Kids Under Age 6
Covid-19: Moderna Seeks Vaccine Authorization For Kids Under Age 6 Moderna says it has submitted a request to the Food and Drug Administration for emergency use authorization of its COVID-19 vaccine for children younger than 6. The company made the announcement on Thursday, April 28, saying it submitted a request to FDA to authorize its vaccine for children from ages 6 months to 6 years old. Moderna's vaccines are currently only authorized for individuals aged 18 and older. "We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children," Moderna CEO Stéphane Bancel said. "We believe mRNA-1273…

SHARE

by Nicole Valinote